foxo4 dri human trial senolytic

foxo4 dri human trial senolytic The disordered p53 transactivation domain is the target of and the compound FOXO4-DRI FOXO4-DRI alleviates age-related testosterone secretion

Name: foxo4 dri human trial senolytic The disordered p53 transactivation domain is the target of and the compound FOXO4-DRI FOXO4-DRI alleviates age-related testosterone secretion
Brand: mlbdaktechniek.nl
SKU: 5529281702
Price: 25.90 USD
Availability: InStock
Rating: 4.769500000000001 (21 reviews)

FOXO4 DRI alleviates age related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice Aging Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry Emerging strategies in senotherapeutics: from broad spectrum senolysis to precision reprogramming npj Aging Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine Buy FOXO4 DRI (Proxofim) Senolytic Peptide For Cellular Renewal

SKU: 5529281702 · From mlbdaktechniek.nl

4.8

USD25.90 USD58.90

Pay in 4 interest-free payments of $6.47 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

Description

TB-500, in contrast, is a simplified synthetic analog representing the minimal active motif responsible for actin binding

Each batch is run through MZ Biolabs using HPLC to verify purity and Mass Spectrometry to confirm molecular identity, ensuring that what is on the label matches what is actually inside